Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Fotini Kalofonou"'
1
Akademický článek
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients
Autor: Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia E. Kottorou, Nikolaos Panagopoulos, Fotini Kalofonou, Fotios Sampsonas, Chrisoula Scopa, Melpomeni Kalofonou, Angelos Koutras, Thomas Makatsoris, Dimitrios Dougenis, Helen Papadaki, Malcolm Brock, Haralabos P. Kalofonos
Publikováno v: Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract A growing number of studies has shed light on the role of the NF-κΒ in non-small-cell lung cancer (NSCLC). To address the significance of major effectors of the NF-κΒ alternative pathway, we investigated the relationship between NF-κΒ2
Externí odkaz: https://doaj.org/article/90d7b523d73d42dd8591096c779df15c
Zobrazit plný text záznamu
3
Expression of intracellular components of the NF-κB alternative pathway (NF-κB2, RelB, NIK and Bcl3) is associated with clinical outcome of NSCLC patients
Autor: Nikolaos Panagopoulos, Dimitrios Dougenis, Malcolm V. Brock, Chrisoula D. Scopa, Helen Papadaki, Melpomeni Kalofonou, Haralabos P. Kalofonos, Thomas Makatsoris, Anastasia E. Kottorou, Fotini Kalofonou, Anna G. Antonacopoulou, Foteinos-Ioannis Dimitrakopoulos, Angelos Koutras, Fotios Sampsonas
Publikováno v: Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
A growing number of studies has shed light on the role of the NF-κΒ in non-small-cell lung cancer (NSCLC). To address the significance of major effectors of the NF-κΒ alternative pathway, we investigated the relationship between NF-κΒ2, RelB, N
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141fbce1a1455800b8c7cb761812eb5a
http://hdl.handle.net/10044/1/74043
Zobrazit plný text záznamu
4
Long-term disease stabilization following treatment with erlotinib in heavily pretreated patients with wild-type epidermal growth factor receptor non-small-cell lung carcinoma: Two case reports
Autor: Maria Pittaka, Haralabos P. Kalofonos, Minas Sakellakis, Angelos Koutras, Efstathios Tsitsopoulos, Fotini Kalofonou
Publikováno v: Molecular and Clinical Oncology. 5:803-806
Lung adenocarcinomas carrying epidermal growth factor receptor (EGFR) mutations have been identified as a unique group of entities that depend on EGFR for their proliferation and metastasis. The introduction of reversible EGFR tyrosine kinase inhibit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f764c99419adb4a1d4cb93b6da09df17
https://doi.org/10.3892/mco.2016.1036
Zobrazit plný text záznamu
5
The clinical significance of NF-κΒ2, RelB, NIK, and BCL3 expression in NSCLC
Autor: Anna G. Antonacopoulou, Chrisoula D. Scopa, Helen Papadaki, Dimitrios Dougenis, Fotinos-Ioannis D. Dimitrakopoulos, Haralabos P. Kalofonos, Anastasia E. Kottorou, Fotini Kalofonou
Publikováno v: Journal of Clinical Oncology. 33:e18511-e18511
e18511 Background: The aim of this study was to evaluate the expression of NF-κΒ2, RelB, NIK and BCL3 in NSCLC and to investigate their associations with clinicopathological parameters and overall ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6c99c8f8e31265e1a7274abe24053d5e
https://doi.org/10.1200/jco.2015.33.15_suppl.e18511
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje